Neuromuscular Junction & Excitation–Contraction Coupling

Nerve Stimulus & Neuromuscular Junction (NMJ)

• Motor‐neuron axon ENTERS a skeletal muscle and BRANCHES extensively.
  • Guarantees simultaneous signaling to multiple fibers.
• Each axon terminal forms ONE neuromuscular junction roughly MIDWAY along the muscle fiber.
  • A microscopic synaptic cleft (~30–50 nm) separates neuron & muscle.
• Axon terminal specializations
  • Synaptic vesicles stuffed with the neurotransmitter acetylcholine (ACh).
  • Voltage-gated $Ca^{2+}$ channels embedded in the pre-synaptic membrane.
• Post-synaptic (sarcolemmal) specializations
  • Highly FOLDED “junctional folds” ⇨ vastly increased surface area.
  • Packed with ACh receptors (AChR) → ligand-gated cation channels.

Events at the NMJ (Neurotransmitter Release)

• AP arrives at axon terminal → opens voltage-gated $Ca^{2+}$ channels.
• $Ca^{2+}$ influx triggers exocytosis of ACh vesicles.
• ACh diffuses across the cleft & binds to AChR on sarcolemma.
• The chemical signal is TERMINATED by
  • Acetylcholinesterase (AChE) enzymatic hydrolysis of ACh.
  • Simple diffusion of remaining ACh out of the cleft.

Generation of an End-Plate Potential (EPP)

• ACh binding OPENS chemically-gated cation channels.
  • $Na^{+}$ influx >> $K^{+}$ efflux ⇨ net positive charge enters fiber.
• Local depolarization ≈ $+10$ to $+15\,\text{mV}$ from rest (EPP).

Sarcolemmal Action Potential (AP)

1. Depolarization
   • EPP reaches THRESHOLD (~$-55\,\text{mV}$) ⇒ nearby voltage-gated $Na^{+}$ channels open.
   • Rapid $Na^{+}$ entry drives membrane toward $+30\,\text{mV}$.
2. Repolarization
   • At peak, $Na^{+}$ channels inactivate, voltage-gated $K^{+}$ channels open.
   • $K^{+}$ exits → membrane returns toward resting potential ($\approx -90\,\text{mV}$).
3. Refractory State
   • During repolarization fiber CANNOT fire a 2ᵈ AP (ensures unidirectional propagation).
   • Resting ionic gradients re-established by $Na^{+}/K^{+}$-ATPase.

Graphs (conceptual)

• Voltage vs. time curve: spike from $-90$ to $+30\,\text{mV}$, then back; $Na^{+}$ and $K^{+}$ channel status annotated.

Excitation–Contraction (E-C) Coupling

1. AP propagates along sarcolemma & dives into T-tubules.
2. T-tubule AP activates voltage-sensitive proteins (dihydropyridine receptors).
3. Conformational change OPENS $Ca^{2+}$-release channels (ryanodine receptors) in terminal cisternae of SR.
4. $Ca^{2+}$ floods cytosol → [Ca^{2+}]_{i} increases ~100-fold.
5. Delay between AP & tension development = latent period (~2–3 ms).

Cross-Bridge Cycling (Sliding-Filament Mechanism)

Resting conditions

• $[Ca^{2+}]_{i}$ low; tropomyosin covers myosin-binding sites on actin.

Upon $Ca^{2+}$ rise

• Two $Ca^{2+}$ ions bind each troponin C.
• Troponin shifts → tropomyosin slides into actin groove, EXPOSING binding sites.

4-Step Cycle (repeats while ATP & $Ca^{2+}$ present)

1. Cross-bridge formation
   • Energized myosin head (ADP + $P_i$ bound; "cocked") attaches to actin.
2. Power stroke
   • Release of ADP + $P_i$ → myosin head pivots to low-energy state.
   • Actin filament pulled toward M-line (sarcomere shortens).
3. Cross-bridge detachment
   • New ATP binds myosin → affinity for actin falls → head detaches.
   • No ATP ⇒ detachment impossible ⇒ rigor mortis.
4. Reactivation (cocking)
   • ATP hydrolysis ($ATP \rightarrow ADP + P_i$) re-energizes head, returning it to pre-stroke position.

Cycle persists as long as $[Ca^{2+}]_{i}$ high.

Muscle Relaxation

• SR Ca^{2+}-ATPase pumps (SERCA) actively move $Ca^{2+}$ back into SR cisternae.
• Falling $[Ca^{2+}]_{i}$ ⇒ $Ca^{2+}$ dissociates from troponin.
• Tropomyosin re-covers binding sites → cross-bridges cease.
• Energized myosin heads can no longer attach; fiber returns to resting length (with aid of elastic elements & antagonist muscles).

Numerical / Statistical References

• Synaptic cleft width ≈ $30$–$50\,\text{nm}$.
• Membrane potentials: Rest $-90\,\text{mV}$, Threshold $-55\,\text{mV}$, Peak $+30\,\text{mV}$.
• Latent period ≈ $2$–$3\,\text{ms}$.

Practical / Clinical Connections

• AChE inhibitors (e.g., nerve gases, myasthenia gravis drugs) prolong ACh action ⇒ spastic paralysis or therapeutic strengthening.
• Dihydropyridine receptor blockers (certain Ca-channel drugs) can alter E-C coupling in cardiac & skeletal muscle variations.
• Rigor mortis: occurs $\approx 3$–$4\,\text{h}$ post-mortem when ATP depleted.

Ethical & Philosophical Notes

• Understanding NMJ pharmacology underpins treatment of neuro-muscular disorders and safe anesthesia.
• Illustrates principle of electro-chemical transduction: conversion of electrical signals to mechanical work—a central theme across physiology.